Lingling C. Yue

Lanzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Venetoclax plus Idarubicin and cytarabine as frontline induction for newly diagnosed acute myeloid leukemia in young, fit adults: a real-world study.

Venetoclax plus Idarubicin and cytarabine as frontline induction for newly diagnosed acute myeloid leukemia in young, fit adults: a real-world study.

Journal: Annals of hematology

Published: January 20, 2026

LRP6 aggravates proliferation, invasion, and immunosuppression in diffuse large B-cell lymphoma: a novel prognostic marker and therapy target.

LRP6 aggravates proliferation, invasion, and immunosuppression in diffuse large B-cell lymphoma: a novel prognostic marker and therapy target.

Journal: Annals of hematology

Published: October 20, 2025

Rapid development of Philadelphia chromosome-negative AML in a CML patient with sustained major molecular response to tyrosine kinase inhibitor therapy.

Rapid development of Philadelphia chromosome-negative AML in a CML patient with sustained major molecular response to tyrosine kinase inhibitor therapy.

Journal: Leukemia research reports

Published: April 15, 2025

Tumor microenvironment in primary central nervous system lymphoma (PCNSL).

Tumor microenvironment in primary central nervous system lymphoma (PCNSL).

Journal: Cancer biology & therapy

Published: November 18, 2024

Chronic myeloid leukemia with e6a2 fusion gene: a case report and literature review

Chronic myeloid leukemia with e6a2 fusion gene: a case report and literature review

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: May 08, 2024

The prognostic value of CD8+ CTLs, CD163+ TAMs, and PDL1 expression in the tumor microenvironment of primary central nervous system lymphoma.

The prognostic value of CD8+ CTLs, CD163+ TAMs, and PDL1 expression in the tumor microenvironment of primary central nervous system lymphoma.

Journal: Leukemia & lymphoma

Published: January 10, 2024

Frequent Gene Mutations and Their Possible Roles in the Pathogenesis, Treatment and Prognosis of Primary Central Nervous System Lymphoma.

Frequent Gene Mutations and Their Possible Roles in the Pathogenesis, Treatment and Prognosis of Primary Central Nervous System Lymphoma.

Journal: World neurosurgery

Published: November 10, 2022

Diffuse large B‑cell lymphoma and monoclonal gammopathy secondary to immune thrombocytopenic purpura: A case report.

Diffuse large B‑cell lymphoma and monoclonal gammopathy secondary to immune thrombocytopenic purpura: A case report.

Journal: Oncology letters

Published: July 21, 2022

Retraction: The lnc-SNHG1 Gene Is Overexpressed and Correlates with Increased White Blood Cell Count, Poor Induction Treatment Response, and Poor Survival Profile in Adult Acute Myeloid Leukemia

Retraction: The lnc-SNHG1 Gene Is Overexpressed and Correlates with Increased White Blood Cell Count, Poor Induction Treatment Response, and Poor Survival Profile in Adult Acute Myeloid Leukemia

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: June 03, 2022

Activated phosphoinositide 3-kinase δ syndrome: a case report

Activated phosphoinositide 3-kinase δ syndrome: a case report

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: January 20, 2022

Mucosal associated lymphoid tissue lymphoma with positive PIM1 expression: a case report

Mucosal associated lymphoid tissue lymphoma with positive PIM1 expression: a case report

Journal: Zhonghua nei ke za zhi

Published: January 04, 2022

Treatment of PCM1-JAK2-positive myeloproliferative neoplasm with eosinophilia using ruxolitinib: a case report

Treatment of PCM1-JAK2-positive myeloproliferative neoplasm with eosinophilia using ruxolitinib: a case report

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 22, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026